These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 16896079

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F, Sinha S, Gadzinowski J, D'Agostino R, Segal R, Guardia C, Mazela J, Liu G, SELECT and STAR Study Investigators.
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, Wiswell TE, Gadzinowski J, Hajdu J, Bernstein G, Sanchez-Luna M, Segal R, Schaber CJ, Massaro J, d'Agostino R, Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group.
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [Abstract] [Full Text] [Related]

  • 7. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
    Halliday HL.
    Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
    [Abstract] [Full Text] [Related]

  • 8. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R.
    Neonatology; 2009 Feb; 95(1):1-5. PubMed ID: 18832858
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R, Ozek E.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD000141. PubMed ID: 19160177
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lucinactant: in neonatal respiratory distress syndrome.
    Moen MD, Perry CM, Wellington K.
    Treat Respir Med; 2005 Jan 21; 4(2):139-45; discussion 146-7. PubMed ID: 15813666
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.